Companies: 10,795·Total market cap: $144.5T
Guided Therapeutics, Inc.

Guided Therapeutics, Inc.

GTHPOTCHealthcare● Active
$0.20
+$0.00(+0.00%)
Market Cap$15340000
P/E Ratio
52W High$0.54
52W Low$0.123

Guided Therapeutics, Inc.(GTHP)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · GTHP · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.77M$0.01M$0.10M$0.01M$0.08M
Cost of Revenue$0.20M$0.01M$0.06M$0.08M$0.06M
Gross Profit$0.57M$0.00M$0.04M($0.07M)$0.02M
Gross Margin %(computed)74.45%28.57%36.73%-523.08%24.69%
Operating Expenses
R&D Expenses$0.47M$0.53M$0.23M$0.08M$0.07M
G&A Expenses$2.31M$1.30M$3.00M$3.01M$2.17M
Total Operating Expenses$2.94M$2.11M$3.49M$3.27M$2.38M
Operating Income($2.37M)($2.11M)($3.46M)($3.33M)($2.36M)
Operating Margin %(computed)-309.26%
Interest Income$0.00M$0.00M$0.01M$0.00M$0.00M
Interest Expense$0.62M$0.38M$0.28M$0.58M$1.15M
Income Before Tax($3.20M)($2.42M)($3.49M)($4.34M)($2.07M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($3.20M)($2.42M)($3.49M)($4.34M)($2.07M)
Net Margin %(computed)-416.69%
Per Share & EBITDA
EPS (Basic)$-0.04$-0.05$-0.07$-0.15$-0.18
Wtd Avg Shares78.41M57.34M51.13M32.51M13.38M
EBITDA($2.47M)($1.94M)($3.13M)($3.69M)($0.92M)
EBITDA Margin %(computed)-322.29%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Guided Therapeutics, Inc.

关于Guided Therapeutics, Inc.(GTHP)损益表

Guided Therapeutics, Inc.(GTHP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,GTHP实现营收$0.00B,毛利润$0.00B(毛利率74.45%),净利润($0.00B)(净利率-416.69%)。

常见问题

GTHP · 4 问

Guided Therapeutics, Inc.(GTHP)2025财年营收为$0.00B,同比up10857.1%。

GTHP revenueGTHP salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09